Hearing implant maker Cochlear is confident its proposed acquisition of a Danish hearing loss device maker will go through, despite the deal catching the attention of the competition watchdog.

So confident is Cochlear CEO Dig Howitt that the acquisition of Demant subsidiary Oticon Medical will go ahead, that he told The Australian Financial Review the company has not considered what impact it will have on its newly announced share buy-back if it is blocked.